Repro Med Systems with ticker code (KRMD) now have 4 analysts in total covering the stock. The consensus rating is ‘Buy’. The target price ranges between 16 and 9 calculating the average target price we see 11.25. Now with the previous closing price of 6.22 this would indicate that there is a potential upside of 80.9%. The 50 day moving average now sits at 4.93 and the 200 moving average now moves to 7.6. The market capitalisation for the company is $278m. You can visit the company’s website by visiting: http://www.korumedical.com
Repro Med Systems, doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems was founded in 1980 and is headquartered in Chester, New York.